A phase I study of varlitinib (VAR; ASLAN001) an oral pan-HER tyrosine kinase inhibitor (TKI) combined with mFOLFIRI chemotherapy in advanced solid tumours

varlitinib (ASLAN001) - ASLAN

A. Tan 1; A. Seet 2; S.P. Choo 2; D. Tai 2; Y.C. Lam 2; W.T. Teng 2; C. Lim 2; K.H. Lim 3; M. Ng 2

Sep 11, 2019